For Better Healthcare Sales Targeting, Follow the Stars

HCP segmentation can be a powerful tool for life sciences companies to target their best sales prospects—but historical data will only get you so far. Data that only looks back can be misleading, and a point-in-time snapshot can make it impossible to tell the difference between HCPs whose volumes are trending down and those who are trending up. To really understand how to best invest your efforts, you need a way to look at physicians’ overall trends in volume and forecasting from a longitudinal perspective. 

PurpleLab designed our proprietary Star Summary Report with this exact need in mind. This report assigns a Star Type to each HCP in our exhaustive database, based on where their volumes are going, not where they’ve been—so you can easily identify the Rising, Rock and Shining Stars you should target to grow your brand. It also lets you deep-dive into physicians to better understand their practices, affiliations and how to reach them.

Find out how you can make the most of your sales investments. Watch this 3-minute recorded demo of the PurpleLab Star Summary Report.

SHARE THIS ARTICLE:

Recommended Articles

COVID-19 has brought us past the tipping point on the issue of health inequity. No doubt, health disparities linked to social determinants of health (SDOH) – such as race, gender, age, ethnicity, income and education level) – have existed since the dawn of the U.S. healthcare system.

Life sciences companies would do both well and good to take advantage of the latest tools and platforms to understand the drivers of health inequity so that they can continue to root it out…

Sales targeting is something medical devices companies definitely can’t afford to get wrong. Whether you’re at PMA (Premarket Approval) trying to maximize initial sales investments, or already in market and working to grow share, you need to get targeting right— right now.